397 related articles for article (PubMed ID: 28333812)
1. Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Obstet Gynecol; 2017 Apr; 129(4):769-770. PubMed ID: 28333812
[TBL] [Abstract][Full Text] [Related]
2. Committee Opinion No. 692: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Committee on Obstetric Practice
Obstet Gynecol; 2017 Apr; 129(4):e90-e95. PubMed ID: 28333820
[TBL] [Abstract][Full Text] [Related]
3. ACOG Committee Opinion No. 767: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Obstet Gynecol; 2019 Feb; 133(2):e174-e180. PubMed ID: 30575639
[TBL] [Abstract][Full Text] [Related]
4. ACOG Committee Opinion No. 767 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period.
Obstet Gynecol; 2019 Feb; 133(2):409-412. PubMed ID: 30681541
[TBL] [Abstract][Full Text] [Related]
5. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
Firoz T; Magee LA; MacDonell K; Payne BA; Gordon R; Vidler M; von Dadelszen P;
BJOG; 2014 Sep; 121(10):1210-8; discussion 1220. PubMed ID: 24832366
[TBL] [Abstract][Full Text] [Related]
6. Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension.
Kilpatrick SJ; Abreo A; Greene N; Melsop K; Peterson N; Shields LE; Main EK
Am J Obstet Gynecol; 2016 Jul; 215(1):91.e1-7. PubMed ID: 26829504
[TBL] [Abstract][Full Text] [Related]
7. Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T; Mundle S; Bracken H; Parvekar S; Mool S; Magee LA; von Dadelszen P; Shochet T; Winikoff B
Lancet; 2019 Sep; 394(10203):1011-1021. PubMed ID: 31378394
[TBL] [Abstract][Full Text] [Related]
8. Identification of factors associated with delayed treatment of obstetric hypertensive emergencies.
Kantorowska A; Heiselman CJ; Halpern TA; Akerman MB; Elsayad A; Muscat JC; Sicuranza GB; Vintzileos AM; Heo HJ
Am J Obstet Gynecol; 2020 Aug; 223(2):250.e1-250.e11. PubMed ID: 32067968
[TBL] [Abstract][Full Text] [Related]
9. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Raheem IA; Saaid R; Omar SZ; Tan PC
BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
[TBL] [Abstract][Full Text] [Related]
10. Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy.
Shi Q; Leng W; Yao Q; Mi C; Xing A
Int J Cardiol; 2015 Jan; 178():162-4. PubMed ID: 25464243
[No Abstract] [Full Text] [Related]
11. Intravenous labetalol versus oral nifedipine for acute hypertension in pregnancy: effects on cerebral perfusion pressure.
Tolcher MC; Fox KA; Sangi-Haghpeykar H; Clark SL; Belfort MA
Am J Obstet Gynecol; 2020 Sep; 223(3):441.e1-441.e8. PubMed ID: 32544404
[TBL] [Abstract][Full Text] [Related]
12. Hypertensive crisis during pregnancy and postpartum period.
Too GT; Hill JB
Semin Perinatol; 2013 Aug; 37(4):280-7. PubMed ID: 23916027
[TBL] [Abstract][Full Text] [Related]
13. Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis.
Shekhar S; Gupta N; Kirubakaran R; Pareek P
BJOG; 2016 Jan; 123(1):40-7. PubMed ID: 26113232
[TBL] [Abstract][Full Text] [Related]
14. Postpartum Hypertension: Etiology, Diagnosis, and Management.
Sharma KJ; Kilpatrick SJ
Obstet Gynecol Surv; 2017 Apr; 72(4):248-252. PubMed ID: 28426127
[TBL] [Abstract][Full Text] [Related]
15. Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.
Gaynor MF; Wright GC; Vondracek S
Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):7-15. PubMed ID: 29265003
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy.
Vermillion ST; Scardo JA; Newman RB; Chauhan SP
Am J Obstet Gynecol; 1999 Oct; 181(4):858-61. PubMed ID: 10521742
[TBL] [Abstract][Full Text] [Related]
17. Oral nifedipine vs. intravenous labetalol for treatment of pregnancy-induced severe pre-eclampsia.
Shi DD; Yang FZ; Zhou L; Wang N
J Clin Pharm Ther; 2016 Dec; 41(6):657-661. PubMed ID: 27578562
[TBL] [Abstract][Full Text] [Related]
18. Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: A Randomized Controlled Trial.
Webster LM; Myers JE; Nelson-Piercy C; Harding K; Cruickshank JK; Watt-Coote I; Khalil A; Wiesender C; Seed PT; Chappell LC
Hypertension; 2017 Nov; 70(5):915-922. PubMed ID: 28893900
[TBL] [Abstract][Full Text] [Related]
19. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.
Rey E; LeLorier J; Burgess E; Lange IR; Leduc L
CMAJ; 1997 Nov; 157(9):1245-54. PubMed ID: 9361646
[TBL] [Abstract][Full Text] [Related]
20. A trial of oral nifedipine and oral labetalol in preeclampsia hypertensive emergency treatment.
Duro-Gómez J; Rodríguez-Marín AB; Giménez de Azcárete M; Duro-Gómez L; Hernández-Angeles C; Arjona-Berral JE; Castelo-Branco C
J Obstet Gynaecol; 2017 Oct; 37(7):864-866. PubMed ID: 28531362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
